Acute, Uncomplicated Human Influenza

Infectious Diseases
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%

Competitive Landscape

1 companies ranked by most advanced pipeline stage

BioCryst Pharmaceuticals
1 program
1
PeramivirPhase 2Small Molecule1 trial
Active Trials
NCT00705406Completed405Est. Oct 2009

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
BioCryst PharmaceuticalsPeramivir

Clinical Trials (1)

Total enrollment: 405 patients across 1 trials

A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza

Start: Jul 2008Est. completion: Oct 2009405 patients
Phase 2Completed

Related Jobs in Infectious Diseases

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space